These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10196168

  • 21. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties.
    Fuhrman B, Oiknine J, Aviram M.
    Atherosclerosis; 1994 Nov; 111(1):65-78. PubMed ID: 7840815
    [Abstract] [Full Text] [Related]

  • 22. Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors.
    Gillotte KL, Hörkkö S, Witztum JL, Steinberg D.
    J Lipid Res; 2000 May; 41(5):824-33. PubMed ID: 10787443
    [Abstract] [Full Text] [Related]

  • 23. Involvement of phospholipids in apolipoprotein B modification during low density lipoprotein oxidation.
    Karakatsani AI, Liapikos TA, Troganis AN, Tsoukatos DC.
    Lipids; 1998 Dec; 33(12):1159-62. PubMed ID: 9930400
    [Abstract] [Full Text] [Related]

  • 24. Participation of the arachidonic acid cascade pathway in macrophage binding/uptake of oxidized low density lipoprotein.
    Beppu M, Watanabe M, Sunohara M, Ohishi K, Mishima E, Kawachi H, Fujii M, Kikugawa K.
    Biol Pharm Bull; 2002 Jun; 25(6):710-7. PubMed ID: 12081134
    [Abstract] [Full Text] [Related]

  • 25. Oxidation-dependent effects of oxidized LDL: proliferation or cell death.
    Han CY, Pak YK.
    Exp Mol Med; 1999 Dec 31; 31(4):165-73. PubMed ID: 10630369
    [Abstract] [Full Text] [Related]

  • 26. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, Ruocco A, Ambrosio G, Montefusco S, Malorni A, Condorelli M, Chiariello M.
    Atherosclerosis; 1995 Dec 31; 118(2):259-73. PubMed ID: 8770320
    [Abstract] [Full Text] [Related]

  • 27. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues.
    Oörni K, Pentikäinen MO, Annila A, Kovanen PT.
    J Biol Chem; 1997 Aug 22; 272(34):21303-11. PubMed ID: 9261142
    [Abstract] [Full Text] [Related]

  • 28. Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages.
    Markakis KP, Koropouli MK, Grammenou-Savvoglou S, van Winden EC, Dimitriou AA, Demopoulos CA, Tselepis AD, Kotsifaki EE.
    J Lipid Res; 2010 Aug 22; 51(8):2191-201. PubMed ID: 20332422
    [Abstract] [Full Text] [Related]

  • 29. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
    Sasabe N, Keyamura Y, Obama T, Inoue N, Masuko Y, Igarashi Y, Aiuchi T, Kato R, Yamaguchi T, Kuwata H, Iwamoto S, Miyazaki A, Hara S, Yoshikawa T, Itabe H.
    Lipids Health Dis; 2014 Mar 14; 13():48. PubMed ID: 24625108
    [Abstract] [Full Text] [Related]

  • 30. Group-II phospholipase A(2) enhances oxidized low density lipoprotein-induced macrophage growth through enhancement of GM-CSF release.
    Kaneko K, Sakai M, Matsumura T, Biwa T, Furukawa N, Shirotani T, Kiritoshi S, Anami Y, Matsuda K, Sasahara T, Shichiri M.
    Atherosclerosis; 2000 Nov 14; 153(1):37-46. PubMed ID: 11058698
    [Abstract] [Full Text] [Related]

  • 31. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR, Loo G.
    J Pineal Res; 1997 May 14; 22(4):203-9. PubMed ID: 9247205
    [Abstract] [Full Text] [Related]

  • 32. The various effects of fractionated oxidized low density lipoproteins on the growth of smooth muscle cells in culture.
    Lin MT, Su WC, Cheng ML, Cheng KS, Chang WC, Wing LH, Jen CJ, Wu HL.
    J Biomed Sci; 1999 May 14; 6(4):260-8. PubMed ID: 10420083
    [Abstract] [Full Text] [Related]

  • 33. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP, Pritchard PH.
    J Lipid Res; 1989 Mar 14; 30(3):305-15. PubMed ID: 2723538
    [Abstract] [Full Text] [Related]

  • 34. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages.
    Hazell LJ, Stocker R.
    Biochem J; 1993 Feb 15; 290 ( Pt 1)(Pt 1):165-72. PubMed ID: 8439285
    [Abstract] [Full Text] [Related]

  • 35. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
    Parthasarathy S, Steinbrecher UP, Barnett J, Witztum JL, Steinberg D.
    Proc Natl Acad Sci U S A; 1985 May 15; 82(9):3000-4. PubMed ID: 3857630
    [Abstract] [Full Text] [Related]

  • 36. Fluorescent adducts formed by reaction of oxidized unsaturated fatty acids with amines increase macrophage viability.
    Riazy M, Lougheed M, Adomat HH, Guns ES, Eigendorf GK, Duronio V, Steinbrecher UP.
    Free Radic Biol Med; 2011 Nov 15; 51(10):1926-36. PubMed ID: 21930200
    [Abstract] [Full Text] [Related]

  • 37. Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells.
    Wang T, Yu WG, Powell WS.
    J Lipid Res; 1992 Apr 15; 33(4):525-37. PubMed ID: 1527476
    [Abstract] [Full Text] [Related]

  • 38. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.
    Hoff HF, O'Neil J, Chisolm GM, Cole TB, Quehenberger O, Esterbauer H, Jürgens G.
    Arteriosclerosis; 1989 Apr 15; 9(4):538-49. PubMed ID: 2751482
    [Abstract] [Full Text] [Related]

  • 39. Inhibition by eicosapentaenoic acid of oxidized-LDL- and lysophosphatidylcholine-induced human coronary artery smooth muscle cell production of endothelin.
    Kohno M, Ohmori K, Wada Y, Kondo I, Noma T, Fujita N, Mizushige K, Mandal AK.
    J Vasc Res; 2001 Apr 15; 38(4):379-88. PubMed ID: 11455209
    [Abstract] [Full Text] [Related]

  • 40. Structural and functional properties of apolipoprotein B in chemically modified low density lipoproteins.
    Vanderyse L, Devreese AM, Baert J, Vanloo B, Lins L, Ruysschaert JM, Rosseneu M.
    Atherosclerosis; 1992 Dec 15; 97(2-3):187-99. PubMed ID: 1466663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.